inspanningsgerelateerde spierschade, sarcopenie exercise-induced muscle damage
Conditions
Interventions
Participants will be randomly assigned to a protein-enhancement group or
control group. Participants are instructed to consume 40g of supplement (30g of
protein)/control powder per day for five week
Sponsors
Radboud Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - 60 years or older - Registered for the Nijmegen Four Days Marches (i.e., able to walk 30-50 km on consequtive days) - A habitual protein intake
Exclusion criteria
Exclusion criteria: - Allergic or sensitive for milk proteins, or lactose or gluten intolerant - Diagnosed type I or type II diabetes mellitus - Diagnosed intestinal diseases influencing the uptake of protein (i.e., active inflammatory bowel disease, Crohn*s disease) - Consumption of other freely available protein supplements during the study period. - If the subject intends to perform additional exercise bouts that cause muscle damage in the 4 days before the single- and multiple exercise bouts.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Circulating creatine kinase concentration is the primary outcome. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters are circulating lactate dehydrogenase concentrations, muscle soreness, and muscle function. | — |
Countries
Netherlands
Outcome results
None listed